The most commonly used tumor markers such as carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9) have insufficient sensitivity and specificity, thus limiting their application in early diagnosis of GC [3]. The gene discussed is CEACAM5; the disease is cancer.